Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
5.80
+0.30 (5.45%)
At close: May 22, 2026, 4:00 PM EDT
5.79
-0.01 (-0.17%)
After-hours: May 22, 2026, 6:27 PM EDT
Q32 Bio Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Q32 Bio stock has a consensus rating of "Buy" and an average price target of $14.33. The average 1-year stock price forecast is 147.07% higher than the current stock price, while the lowest is $10 (+72.41%) and the highest is $20 (+244.83%).
Price Target: $14.33 (+147.07%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Q32 Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 0 | 0 | 0 | 1 |
| Hold | 5 | 5 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Initiates $14 | Buy | Initiates | $14 | +141.38% | May 22, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +124.14% | May 5, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +124.14% | Feb 25, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +158.62% | Mar 12, 2025 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $22 → $3 | Buy → Hold | Downgrades | $22 → $3 | -48.28% | Feb 11, 2025 |
Financial Forecast
Revenue This Year
n/a
from 53.74M
Revenue Next Year
n/a
EPS This Year
-1.86
from 2.42
EPS Next Year
-2.26
from -1.86
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.30 | -2.10 | |
| Avg | -1.86 | -2.26 | |
| Low | -2.16 | -2.56 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.